Status:
COMPLETED
HEmoFiltration With Citric Acid Anticoagulation
Lead Sponsor:
Medical University of Gdansk
Conditions:
Acute Kidney Injury
Acute Kidney Failure
Eligibility:
All Genders
18-90 years
Brief Summary
Prospective observational study of all consecutive cardio-vascular surgical patients treated with post-dilution hemofiltration with regional citrate anticoagulation as first-choice anticoagulation met...
Detailed Description
All consecutive cardio-vascular surgery patients treated with post-dilution hemofiltration with regional citrate anticoagulation (HF RCA) from August 2015 through November 2017 were included to prospe...
Eligibility Criteria
Inclusion
- cardiac and vascular surgery patients treated with continuous hemofiltration with regional citrate anticoagulation
Exclusion
- severe chronic liver disease, acute liver injury with INR \> 2, and refractory shock with lactate increasing above 8 mmol/L
Key Trial Info
Start Date :
August 11 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT03836742
Start Date
August 11 2015
End Date
December 31 2017
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Romuald Lango
Gdansk, Polska, Poland, 80-516